カンデサルタン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "カンデサルタン" in Japanese language version.

refsWebsite

Global rank Japanese rank

6nih.gov

4^th place

24^th place

5doi.org

2^nd place

6^th place

1nature.com

234^th place

363^rd place

1pmda.go.jp

6,690^th place

394^th place

1ahajournals.org

3,608^th place

7,627^th place

1worldcat.org

5^th place

19^th place

1toyokeizai.net

1,531^st place

103^rd place

1kyoto-u.ac.jp

2,913^th place

283^rd place

1ebm-library.jp

low place

1medicaladver.com

low place

1st-note.com

low place

1nikkeibp.co.jp

1,415^th place

95^th place

1rief-jp.org

low place

1mhlw.go.jp

1,656^th place

110^th place

1yakuji.co.jp

low place

2,265^th place

1mixonline.jp

low place

4,576^th place

ahajournals.org

Ogihara, Toshio; Nakao, Kazuwa; Fukui, Tsuguya; Fukiyama, Kohshiro; Ueshima, Kenji; Oba, Koji; Sato, Tosiya; Saruta, Takao (2008-02). “Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks: Candesartan Antihypertensive Survival Evaluation in Japan Trial” (英語). Hypertension 51 (2): 393–398. doi:10.1161/HYPERTENSIONAHA.107.098475. ISSN 0194-911X.

doi.org

Pfeffer M, Swedberg K, Granger C, Held P, McMurray J, Michelson E, Olofsson B, Ostergren J, Yusuf S, Pocock S (2003). “Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme”. Lancet 362 (9386): 759–66. doi:10.1016/S0140-6736(03)14282-1. PMID 13678868.
Julius S, Nesbitt SD, Egan BM (July 2006). “Feasibility of treating prehypertension with an angiotensin-receptor blocker”. New England Journal of Medicine 354 (16): 1685–97. doi:10.1056/NEJMoa060838. PMID 16537662.
Hosaka M, Metoki H, Satoh M, Ohkubo T, Asayama K, Kikuya M et al. (2015). “Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide.”. Hypertens Res 38 (10): 701-7. doi:10.1038/hr.2015.64. PMID 26041602.
Mizuno, K. (1992). “Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats.”. Life Sci. 51 (20): PL183-187. doi:10.1016/0024-3205(92)90627-2. PMID 1435062.
Ogihara, Toshio; Nakao, Kazuwa; Fukui, Tsuguya; Fukiyama, Kohshiro; Ueshima, Kenji; Oba, Koji; Sato, Tosiya; Saruta, Takao (2008-02). “Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular Risks: Candesartan Antihypertensive Survival Evaluation in Japan Trial” (英語). Hypertension 51 (2): 393–398. doi:10.1161/HYPERTENSIONAHA.107.098475. ISSN 0194-911X.

ebm-library.jp

“CASE-J_循環器トライアルデータベース”. www.ebm-library.jp. 2021年11月15日閲覧。

kyoto-u.ac.jp

“[https://www.kyoto-u.ac.jp/sites/default/files/embed/jaaboutevents_newsofficekenkyukokusaikenkyunews2014documents150227_102.pdf 臨床研究ＣＡＳＥ－Ｊ試験に関する調査報告書]”. 京都大学. 2021年11月15日閲覧。

medicaladver.com

“ブロプレス／国内2番目のARB | 医薬広告DataBase”. 医薬広告DataBase | (2010年3月25日). 2021年11月15日閲覧。

mhlw.go.jp

“別紙”. 厚生労働省. 2021年11月15日閲覧。

mixonline.jp

“厚労省　武田薬品に誇大広告で業務改善命令　CASE-Jの“ゴールデン・クロス”で | ニュース | ミクスOnline”. www.mixonline.jp. 2021年11月15日閲覧。

nature.com

Hosaka M, Metoki H, Satoh M, Ohkubo T, Asayama K, Kikuya M et al. (2015). “Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide.”. Hypertens Res 38 (10): 701-7. doi:10.1038/hr.2015.64. PMID 26041602.

nih.gov

pubmed.ncbi.nlm.nih.gov

Pfeffer M, Swedberg K, Granger C, Held P, McMurray J, Michelson E, Olofsson B, Ostergren J, Yusuf S, Pocock S (2003). “Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme”. Lancet 362 (9386): 759–66. doi:10.1016/S0140-6736(03)14282-1. PMID 13678868.
Julius S, Nesbitt SD, Egan BM (July 2006). “Feasibility of treating prehypertension with an angiotensin-receptor blocker”. New England Journal of Medicine 354 (16): 1685–97. doi:10.1056/NEJMoa060838. PMID 16537662.
Hosaka M, Metoki H, Satoh M, Ohkubo T, Asayama K, Kikuya M et al. (2015). “Randomized trial comparing the velocities of the antihypertensive effects on home blood pressure of candesartan and candesartan with hydrochlorothiazide.”. Hypertens Res 38 (10): 701-7. doi:10.1038/hr.2015.64. PMID 26041602.
Mizuno, K. (1992). “Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats.”. Life Sci. 51 (20): PL183-187. doi:10.1016/0024-3205(92)90627-2. PMID 1435062.
Ogihara, T. (Jul–Aug 1993). “Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension.”. Clin Ther. 15 (4): 684–91. PMID 8221818.
福井次矢 (2006). “我が国の大規模試験 CASE-J”. 日本臨牀 64(増刊号6): 449-453. PMID 16981578.